Société Acerus Pharmaceuticals Corporation
Actions
ASPCF
CA00444G4051
Produits pharmaceutiques
Métier
Nombre d'employés: 14
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 | |
Philippe Savard
LAW | General Counsel | - | 04/07/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Stephen Gregory
BRD | Director/Board Member | - | 14/07/11 |
Geoff Cotton
BRD | Director/Board Member | - | 01/05/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 7 702 297 | 662 312 ( 8,599 %) | 0 | 8,599 % |
Coordonnées société
Acerus Pharmaceuticals Corp.
7025 Langer Drive Suite 205
L5N 0E8, Mississauga
+
http://www.aceruspharma.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+37,74% | 723 Md | |
+34,61% | 595 Md | |
-2,07% | 369 Md | |
+20,25% | 332 Md | |
+2,99% | 282 Md | |
+17,02% | 244 Md | |
+10,00% | 208 Md | |
-4,17% | 205 Md | |
+7,43% | 166 Md |